142 related articles for article (PubMed ID: 19409042)
41. Cotransfected sodium iodide symporter and human tyroperoxidase genes following human telomerase reverse transcriptase promoter for targeted radioiodine therapy of malignant glioma cells.
Li W; Tan J; Wang P; Wu P
Cancer Biother Radiopharm; 2011 Aug; 26(4):443-51. PubMed ID: 21797672
[TBL] [Abstract][Full Text] [Related]
42. Iodide kinetics and experimental (131)I therapy in a xenotransplanted human sodium-iodide symporter-transfected human follicular thyroid carcinoma cell line.
Smit JW; Schröder-van der Elst JP; Karperien M; Que I; Stokkel M; van der Heide D; Romijn JA
J Clin Endocrinol Metab; 2002 Mar; 87(3):1247-53. PubMed ID: 11889195
[TBL] [Abstract][Full Text] [Related]
43. microRNA-339-5p modulates Na+/I- symporter-mediated radioiodide uptake.
Lakshmanan A; Wojcicka A; Kotlarek M; Zhang X; Jazdzewski K; Jhiang SM
Endocr Relat Cancer; 2015 Feb; 22(1):11-21. PubMed ID: 25404690
[TBL] [Abstract][Full Text] [Related]
44. Transcription factor Nkx-2.5 induces sodium/iodide symporter gene expression and participates in retinoic acid- and lactation-induced transcription in mammary cells.
Dentice M; Luongo C; Elefante A; Romino R; Ambrosio R; Vitale M; Rossi G; Fenzi G; Salvatore D
Mol Cell Biol; 2004 Sep; 24(18):7863-77. PubMed ID: 15340050
[TBL] [Abstract][Full Text] [Related]
45. Kinetics of iodide uptake and efflux in various human thyroid cancer cells by expressing sodium iodide symporter gene via a recombinant adenovirus.
Lee WW; Lee B; Kim SJ; Jin J; Moon DH; Lee H
Oncol Rep; 2003; 10(4):845-9. PubMed ID: 12792733
[TBL] [Abstract][Full Text] [Related]
46. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.
Cengic N; Baker CH; Schütz M; Göke B; Morris JC; Spitzweg C
J Clin Endocrinol Metab; 2005 Aug; 90(8):4457-64. PubMed ID: 15941870
[TBL] [Abstract][Full Text] [Related]
47. Retinoic acid-induced stimulation of sodium iodide symporter expression and cytotoxicity of radioiodine in prostate cancer cells.
Spitzweg C; Scholz IV; Bergert ER; Tindall DJ; Young CY; Göke B; Morris JC
Endocrinology; 2003 Aug; 144(8):3423-32. PubMed ID: 12865321
[TBL] [Abstract][Full Text] [Related]
48. The rat sodium iodide symporter gene permits more effective radioisotope concentration than the human sodium iodide symporter gene in human and rodent cancer cells.
Heltemes LM; Hagan CR; Mitrofanova EE; Panchal RG; Guo J; Link CJ
Cancer Gene Ther; 2003 Jan; 10(1):14-22. PubMed ID: 12489024
[TBL] [Abstract][Full Text] [Related]
49. Regulation of sodium iodide symporter gene expression by Rac1/p38β mitogen-activated protein kinase signaling pathway in MCF-7 breast cancer cells.
Kogai T; Liu YY; Mody K; Shamsian DV; Brent GA
J Biol Chem; 2012 Jan; 287(5):3292-300. PubMed ID: 22157753
[TBL] [Abstract][Full Text] [Related]
50. The pan-DAC inhibitor LBH589 is a multi-functional agent in breast cancer cells: cytotoxic drug and inducer of sodium-iodide symporter (NIS).
Fortunati N; Catalano MG; Marano F; Mugoni V; Pugliese M; Bosco O; Mainini F; Boccuzzi G
Breast Cancer Res Treat; 2010 Dec; 124(3):667-75. PubMed ID: 20213084
[TBL] [Abstract][Full Text] [Related]
51. Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone.
Willhauck MJ; Sharif-Samani B; Senekowitsch-Schmidtke R; Wunderlich N; Göke B; Morris JC; Spitzweg C
Breast Cancer Res Treat; 2008 May; 109(2):263-72. PubMed ID: 17636401
[TBL] [Abstract][Full Text] [Related]
52. Regulation of the sodium/iodide symporter by retinoids--a review.
Schmutzler C
Exp Clin Endocrinol Diabetes; 2001; 109(1):41-4. PubMed ID: 11573138
[TBL] [Abstract][Full Text] [Related]
53. In vivo expression and function of the sodium iodide symporter following gene transfer in the MATLyLu rat model of metastatic prostate cancer.
La Perle KM; Shen D; Buckwalter TL; Williams B; Haynam A; Hinkle G; Pozderac R; Capen CC; Jhiang SM
Prostate; 2002 Feb; 50(3):170-8. PubMed ID: 11813209
[TBL] [Abstract][Full Text] [Related]
54. Activation of the PI3 kinase pathway by retinoic acid mediates sodium/iodide symporter induction and iodide transport in MCF-7 breast cancer cells.
Ohashi E; Kogai T; Kagechika H; Brent GA
Cancer Res; 2009 Apr; 69(8):3443-50. PubMed ID: 19351850
[TBL] [Abstract][Full Text] [Related]
55. Endogenous NIS expression in triple-negative breast cancers.
Renier C; Yao C; Goris M; Ghosh M; Katznelson L; Nowles K; Gambhir SS; Wapnir I
Ann Surg Oncol; 2009 Apr; 16(4):962-8. PubMed ID: 19184238
[TBL] [Abstract][Full Text] [Related]
56. Wild-Type P53 Induces Sodium/Iodide Symporter Expression Allowing Radioiodide Therapy in Anaplastic Thyroid Cancer.
Liu L; Li D; Chen Z; Yang J; Ma Y; Cai H; Shan C; Lv Z; Zhang X
Cell Physiol Biochem; 2017; 43(3):905-914. PubMed ID: 28957796
[TBL] [Abstract][Full Text] [Related]
57. The sodium iodide symporter (NIS): regulation and approaches to targeting for cancer therapeutics.
Kogai T; Brent GA
Pharmacol Ther; 2012 Sep; 135(3):355-70. PubMed ID: 22750642
[TBL] [Abstract][Full Text] [Related]
58. Functional expression of sodium iodide symporter (NIS) in human breast cancer tissue.
Upadhyay G; Singh R; Agarwal G; Mishra SK; Pal L; Pradhan PK; Das BK; Godbole MM
Breast Cancer Res Treat; 2003 Jan; 77(2):157-65. PubMed ID: 12602914
[TBL] [Abstract][Full Text] [Related]
59. Uptake and antiproliferative effect of molecular iodine in the MCF-7 breast cancer cell line.
Arroyo-Helguera O; Anguiano B; Delgado G; Aceves C
Endocr Relat Cancer; 2006 Dec; 13(4):1147-58. PubMed ID: 17158760
[TBL] [Abstract][Full Text] [Related]
60. Mechanisms related to [18F]fluorodeoxyglucose uptake of human colon cancers transplanted in nude mice.
Chung JK; Lee YJ; Kim C; Choi SR; Kim M; Lee K; Jeong JM; Lee DS; Jang JJ; Lee MC
J Nucl Med; 1999 Feb; 40(2):339-46. PubMed ID: 10025844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
